BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murphy SE, Bicanic T. Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis. Front Cell Infect Microbiol 2021;11:759408. [PMID: 34970504 DOI: 10.3389/fcimb.2021.759408] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Da CSMD, Alves CA, Ribeiro LSM, Macedo MA, Da SALS, Cunha FN, De LBVSL, Silva DF, Lima EO, De OF. Bioprospecting of the antifungal activity of Patchouli essential oil (Pogostemon cablin Benth) against strains of the genus Candida. J Med Plants Res 2023;17:1-7. [DOI: 10.5897/jmpr2022.7257] [Reference Citation Analysis]
2 Sharma M, Chakrabarti A. Candidiasis and Other Emerging Yeasts. Curr Fungal Infect Rep 2023. [DOI: 10.1007/s12281-023-00455-3] [Reference Citation Analysis]
3 Silva BLR, Simão G, Campos CDL, Monteiro CRAV, Bueno LR, Ortis GB, Mendes SJF, Moreira IV, Maria-Ferreira D, Sousa EM, Vidal FCB, Monteiro CA, Monteiro-Neto V, Fernandes ES. In Silico and In Vitro Analysis of Sulforaphane Anti-Candida Activity. Antibiotics (Basel) 2022;11. [PMID: 36551499 DOI: 10.3390/antibiotics11121842] [Reference Citation Analysis]
4 Yang Z, Zhang F, Li D, Wang S, Pang Z, Chen L, Li R, Shi D. Correlation Between Drug Resistance and Virulence of Candida Isolates from Patients with Candidiasis. Infect Drug Resist 2022;15:7459-73. [PMID: 36544991 DOI: 10.2147/IDR.S387675] [Reference Citation Analysis]
5 Li H, Yang J, Zhang X, Xu X, Song F, Li H. Biocontrol of Candida albicans by Antagonistic Microorganisms and Bioactive Compounds. Antibiotics 2022;11:1238. [DOI: 10.3390/antibiotics11091238] [Reference Citation Analysis]
6 Bonvicini F, Locatelli A, Morigi R, Leoni A, Gentilomi GA. Isatin Bis-Indole and Bis-Imidazothiazole Hybrids: Synthesis and Antimicrobial Activity. Molecules 2022;27:5781. [DOI: 10.3390/molecules27185781] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Gerstein AC, Sethi P. Experimental evolution of drug resistance in human fungal pathogens. Curr Opin Genet Dev 2022;76:101965. [PMID: 35952557 DOI: 10.1016/j.gde.2022.101965] [Reference Citation Analysis]
8 Barantsevich N, Barantsevich E. Diagnosis and Treatment of Invasive Candidiasis. Antibiotics 2022;11:718. [DOI: 10.3390/antibiotics11060718] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
9 Chen L, Luo L, Chen Y, Wang Y, Li J, Zheng X, Yang T, Hu J. Antifungal Strategy in Patients with Invasive Fungal Disease Associated with Hematological Malignancies Based on Risk Stratification. Can J Infect Dis Med Microbiol 2022;2022:1743596. [PMID: 35432663 DOI: 10.1155/2022/1743596] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Bugli F, Massaro F, Buonocore F, Saraceni PR, Borocci S, Ceccacci F, Bombelli C, Di Vito M, Marchitiello R, Mariotti M, Torelli R, Sanguinetti M, Porcelli F. Design and Characterization of Myristoylated and Non-Myristoylated Peptides Effective against Candida spp. Clinical Isolates. Int J Mol Sci 2022;23:2164. [PMID: 35216297 DOI: 10.3390/ijms23042164] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
11 Kovács R. Special Issue: Alternative Therapeutic Approaches of Candida Infections. JoF 2022;8:170. [DOI: 10.3390/jof8020170] [Reference Citation Analysis]